Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Aug 27;40(6):1356. doi: 10.1007/s10637-022-01296-6

Correction to: Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine

Haiqin Ping 1, Wenjun Yu 1, Xiaoming Gong 1, Xin Tong 1, Cheyu Lin 1, Zhaojun Chen 1, Caiyun Cai 1, Kai Guo 1, Hengning Ke 1,2,3,✉
PMCID: PMC9828853  PMID: 36029352

Correction to: Investigational New Drugs https://doi.org/10.1007/s10637-022-01290-y

Author information was missing and will be added.

"Haiqin Ping and Wenjun Yu are joint first authors."

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Haiqin Ping, Email: 1723392486@qq.com.

Wenjun Yu, Email: ywj341022@163.com.

Xiaoming Gong, Email: 15172734978@163.com.

Xin Tong, Email: 2019203030011@whu.edu.cn.

Cheyu Lin, Email: Alan_lin@heekis.com.

Zhaojun Chen, Email: czj318mi@163.com.

Caiyun Cai, Email: 2020283030080@whu.edu.cn.

Kai Guo, Email: guokai4937@163.com.

Hengning Ke, Email: kehengning@znhospital.cn.

Articles from Investigational New Drugs are provided here courtesy of Springer

RESOURCES